A. Ratcliff

发表

HIV-1 Entry and Fusion Inhibitors: Mechanisms and Resistance

E. Arts, A. Finzi, Colin M. Venner, 2017 .

Multifaceted Mechanisms of HIV Inhibition and Resistance to CCR5 Inhibitors PSC-RANTES and Maraviroc

E. Arts, A. Marozsan, D. Dudley, 2013, Antimicrobial Agents and Chemotherapy.

Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1

J. Bailey, T. Hope, Yong Gao, 2020, Journal of Virology.

Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope

E. Arts, A. Finzi, Jason P Knapp, 2022, Journal of Virology.

HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120

E. Arts, W. Shi, A. Ratcliff, 2012, Journal of Virology.

Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope

E. Arts, A. Finzi, Jason P Knapp, 2022, Journal of virology.

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

E. Arts, J. Plantier, D. Tebit, 2016, AIDS research and human retroviruses.

Mechanisms of CCR5 Agonist/Antagonist Inhibition of HIV-1 Entry and In Vitro Selection of Virus Resistant to Maraviroc

A. Ratcliff, 2013 .

Use of taxon-specific competitive-priming PCR to study host specificity, hybridization, and intergroup gene flow in intersterility groups of Heterobasidion annosum.

M. Garbelotto, T. Bruns, W. Otrosina, 1996 .

Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA

John A. Robinson, J. Karn, G. Varani, 2011, PLoS pathogens.

Cellular fatty acid synthase is required for late stages of HIV-1 replication

Philip F. Hughes, T. Haystead, D. Loiselle, 2017, Retrovirology.

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.

Timothy A J Haystead, Laura G. Dubois, Philip F. Hughes, 2016, Cell chemical biology.

HIV-1 Entry, Inhibitors, and Resistance

E. Arts, M. Lobritz, A. Ratcliff, 2010, Viruses.

HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120

E. Arts, W. Shi, A. Ratcliff, 2012, Journal of Virology.

Cellular fatty acid synthase is required for late stages of HIV-1 replication

Philip F. Hughes, T. Haystead, J. Arcos, 2017, Retrovirology.

Effect of Natural Polymorphisms in the HIV-1 CRF02_AG Protease on Protease Inhibitor Hypersusceptibility

M. Soares, Matthew S. Lalonde, E. Arts, 2012, Antimicrobial Agents and Chemotherapy.